Iridex (IRIX) Cash from Investing Activities (2011 - 2026)
Iridex (IRIX) posted Cash from Investing Activities of -$50000.0 for Q3 2026, up 50.5% on a QoQ basis from -$101000.0 in Q2 2026, and down 284.62% year-over-year from $27083.3 in Q3 2025.
Powered by 
Analysis
Iridex (IRIX) Cash from Investing Activities (2011 - 2026) Analysis & Trends
Iridex has reported Cash from Investing Activities for 16 years, with the latest figure at -$50000.0 in Q3 2026.
- On a quarterly basis, Cash from Investing Activities fell 284.62% year-over-year to -$50000.0 in Q3 2026; TTM through Jul 2026 was -$270000.0, a 694.12% decrease from a year earlier, with the FY2026 full-year figure at -$143000.0, down 1000.0% from the prior year.
- Cash from Investing Activities was -$50000.0 for Q3 2026 at Iridex, up from -$101000.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was $32000.0 in Q4 2023, with the low at -$5.5 million in Q1 2022.
- Average Cash from Investing Activities over 5 years is -$343000.0, with a median of -$34500.0 recorded in 2022.
- The sharpest annual moves came in 2023 and 2025: Cash from Investing Activities jumped 138.55% in 2023, then slumped 1200.0% in 2025.
- Over 5 years, Cash from Investing Activities stood at -$83000.0 in 2022, then surged by 138.55% to $32000.0 in 2023, then sank by 128.12% to -$9000.0 in 2024, then sank by 44.44% to -$13000.0 in 2025, then slumped by 284.62% to -$50000.0 in 2026.
- The last three Cash from Investing Activities figures came in at -$50000.0 (Q3 2026), -$101000.0 (Q2 2026), and -$106000.0 (Q1 2026), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | -26.60 Mn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | -1.62 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | -639.00 Mn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | -1.96 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | -193.20 Mn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | -222.00 Mn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 329.80 Mn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Iridex | 12.22 Mn | 7.54 Mn | 4.30 Mn | -50,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 4, 2026 | -50,000.00 |
| Apr 4, 2026 | -101,000.00 |
| Jan 3, 2026 | -106,000.00 |
| Sep 27, 2025 | -13,000.00 |
| Jun 28, 2025 | -13,000.00 |
| Mar 29, 2025 | -11,000.00 |
| Dec 28, 2024 | -9,000.00 |
| Sep 28, 2024 | -1,000.00 |
| Mar 30, 2024 | -3,000.00 |
| Dec 30, 2023 | 32,000.00 |
| Sep 30, 2023 | -82,000.00 |
| Jul 1, 2023 | -16,000.00 |
| Apr 1, 2023 | -43,000.00 |
| Dec 31, 2022 | -83,000.00 |
| Oct 1, 2022 | -57,000.00 |
| Jul 2, 2022 | -120,000.00 |
| Apr 2, 2022 | -26,000.00 |
| Jan 1, 2022 | -5.47 Mn |
| Apr 3, 2021 | -5.42 Mn |
| Sep 26, 2020 | -5,000.00 |